Home/Filings/4/A/0001062993-25-001501
4/A//SEC Filing

McManus Matthew 4/A

Accession 0001062993-25-001501

CIK 0000842023other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:38 PM ET

Size

5.7 KB

Accession

0001062993-25-001501

Insider Transaction Report

Form 4/AAmended
Period: 2024-08-15
McManus Matthew
President - DGS
Transactions
  • Award

    Performance Restricted Stock Units

    2024-08-15+15,82515,825 total
    Common Stock (15,825 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F2]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001908268

Filing Metadata

Form type
4/A
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:38 PM ET
Size
5.7 KB